Capital Fund Management (CFM)
ANIP icon

Capital Fund Management (CFM)’s ANI Pharmaceuticals ANIP Stock Holding History

Capital Fund Management (CFM)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,345
Closed -$391K – 1538
2019
Q4 		$391K Buy
+6,345
New +$420K ﹤0.01% 1494
2018
Q3 		– Sell
-10,100
Closed -$675K – 1929
2018
Q2 		$675K Buy
10,100
+5,100
+102% +$318K ﹤0.01% 1480
2018
Q1 		$291K Buy
+5,000
New +$317K ﹤0.01% 1645
2015
Q1 		– Sell
-6,400
Closed -$361K – 1416
2014
Q4 		$361K Buy
+6,400
New +$282K ﹤0.01% 1267

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Fund Management (CFM)'s ANIP Position: Q1 2020 in Review

Capital Fund Management (CFM) sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 6,345 shares — an estimated $391K sold.

Capital Fund Management (CFM) first reported a position in ANIP in Q4 2014 and held it in 4 quarters. The position peaked at $675K in Q2 2018. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

  • Capital Fund Management (CFM) reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 6,345 ANI Pharmaceuticals shares in Q1 2020, an estimated $391K.
  • Capital Fund Management (CFM) first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s ANI Pharmaceuticals position peaked at $675K in Q2 2018.
  • 140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2020, filed 13 May 2020.